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SUMMARY
Diabetic glomerulopathy has been traced to shifts in balance between the synthetic and
degradative pathways of the glomerular basernent membrane, a key player in the
permselectivity of macromolecules. The goal of this study was to trace the expression
and iocalization of MT 1 -MMP and its activating enzyme furin, key proteins involved in
basement membrane turnover, in short- and long-term diabetic rat renal tissues.
To verify these assumptions, the expression of MT1-MMP and furin was evaluated in
young and old, control and diabetic rat renal tissues. Immunoelectron microscopy
revealed that the overail expression of MTI-MMP and ftirin is reduced in plasma
membranes of ceils of old normoglycemic animais, a phenomenon that is exacerbated in
long-term diabetic animais. This observation supports the prevailing theory that diabetes
fosters an acceleration in the aging process. Western biots were also performed on
glomenilar lysates. Interestingiy, while biochemicai resuits confirmed a decrease in
MTY-MMP expression, an increase in furin was observed. Immunocytochemical studies
resolved this discrepancy by tracing the increased furin expression in Golgi and ER
membranes of podocytes, indicating that furin rnight be retained in the biosynthetic
pathway in a diabetic environment. This suggests that whiie furin is overexpressed in
diabetes, it is unabie to reach the ccii surface to contribute to extraceliular matrix
turnover.
Key words: diabetes, giomeruloscierosis, MT1-MMP, ftirin, GBM turnover
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SOMMAIRE
Les glomérulopathies diabétiques sont caractérisées par un déséquilibre entre les voies de
synthèse et de dégradation de la membrane basale gloméntiaire (MBG), une structure
essentielle à la perrnsélectivité des macromolécules. L’objectif était de suivre
l’expression et la localisation de la MTY-MMP et de son enzyme d’activation la furine,
deux protéines essentielles pour le renouvellement de la MBG, dans les reins de rats
diabétiques.
Pour vérifier cela, l’expression de la MT1-MMP et de la furine a été évaluée dans les
tissus rénaux de rats jeunes et âgés, contrôles et diabétiques. L’expression de la Mil
MMP et de la furine semble être réduite dans les membranes plasmiques des cellules
glomérulaires des animaux âgés, mais par ailleurs normaux, un phénomène qui est
aggravé chez les animaux diabétiques. Cette observation appuie la théorie selon laquelle
le diabète accélère le processus normal de vieillissement. L’immunobuvardage sur des
lysats glomérulaires a effectivement confiniié une baisse d’expression de la Mil-MMP.
En revanche, en immunocytochimie, une hausse de niveau d’expression de la furine a été
observée. Cette discordance a été résolue par immunocytochimie par la détection accrue
de furine dans les membranes du Golgi et du réticulum endoplasmique. Cette
observation suggère que la furine est retenue dans la voie biosynthétique des podocytes
lors du diabète. Malgré sa sur-expression, la furine semble incapable d’atteindre la
surface cellulaire pour contribuer au renouvellement de la MBG.
Mots clés: diabète, glornérulosclerose, MT1-MMP, furine, renouvellement de la MBG
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1Introduction
The human kidney is a veritable marvel of creation. There is no need to question
the absolute indispensability of kidneys once we leam that the total volume of our
circulating bÏood passes through the kidneys once every five minutes! This
amounts to a rough total of seventy liters of blood plasma per day! The kidneys
not only inspire us to cite staggering statistics that require exclamation points, but
also perform the extraordinary and vital tasks of overseeing water and electrolyte
homeostasis, regulating blood and extracellular fluid chemical composition,
maintaining blood pressure through release of the renin hormone, stimulating red
blood celi synthesis through release of erythroprotein, and simply being an ail
around great pair oforgans (Leeson and Leeson, 1981).
Anatomically speaking, the individual kidney resembles a bean. . . or is it the bean
that resembles a kidney? Regardless of any phulosophical debate, the kidneys are
located in the posterior part ofthe upper abdomen, and each kidney is about 10-12
centimeters in iength and 2.5 centimeters thick (Leeson and Leeson, 1981). The
three most prominent anatomical features seen in a transverse kidney section are
the outer cortex, the inner medulla, and the pelvis, a hollow inner structure that
joins with the ureters (Tisher and Madsen, 1986). In the medial sections of each
kidney is an indentation calied the hilum which serves as an exit point for the
ureter and gives way to nerves, blood and lymphatic vessels entering and leaving
(Leeson and Leeson, 1981). Other distinguishing features include the renal
2capsule serving as a protective membrane, as welÏ as right and left adrenal glands
which, as the name implies, sit snugly on top ofeach kidney.
The Nephron
The interior medulla of each kidney is adomed with 8-18 pyramids that are
striated in appearance. These are positioned with their tips, the renal papillae,
facing towards the hulum and their bases aligned with the edge of the renal cortex
(Leeson and Leeson, 1981). The renal cortex extends between each renal pyramid
creating structures calÏed renal columns. If we were to zoom into the medulla and
cortex we would encounter a myriad of tiny microscopic convoluted structures
called nephrons. At last, with the acquaintance of the nephron, we make the leap
from structure to function and are doser to understanding the essence of the
kidney. Also known as the functional units of the kidney, nephrons number
slightÏy over one million in each kidney (Tisher and Madsen, 1986). Embedded
in both the cortex and medulla, they are assigned the delicate task of filtering the
blood plasma, that is, producing a filtrate while retaining the cellular elements of
the blood and plasma proteins in circulation (Farquhar, 1991). The nephron may
well exhibit a baffling hodge-podge of loops and twists and tums reminiscent of a
Cirque du Soleil contortionist, but within this seemingly disorderly arrangement
exists an highly organised and complex system of gradients through which
altemating functions of secretions and reabsorptions result in the production of
urine.
3The essential components of the nephron are the glomerulus and Bowman’s
capsule, the proximal convoluted tubule, the ascending and descending limbs of
the loop of Henle, and the distal convoluted tubule (Tisher and Madsen, 1986).
The glomerulus and Bowman’s capsule form the renal corpuscule which lies in
the cortex while the renal tubule comprising of the thin limbs and connecting
segment, the proximal and distal tubules, extends into the medullar pyramid
(Leeson and Leeson, 1981). Given that we are interested in the production ofthe
ultrafiltrate of blood plasma, the following information will focus solely on the
renal glomerulus where this process takes place.
Ihe Glomerulus
The glomerulus has been accurately yet perhaps unglamorously described as a tufi
of capillaries. Within the layers of the Bowman’s capsule, blood enters the
glomerulus through the afferent arteriole and exits through the same opening by
the efferent arteriole. The afferent arteriole branches into a capillary network
where hydrostatic blood pressure forces the glomerular filtrate out into the
capsular space to eventually be funneled into the renal tubule where reabsorption
of most ftuids and saits take place (Farquhar, 1991). A transversal cut of the
glomerular capillary tuft unveils where ultraffitration takes place. The different
structures observed, collectively called the glomerular wall, impose a precise
permselectivity size and charge barrier to the blood plasma and will be
extensively reviewed in the following paragraphs.
4The Glomerular WaII
In a remarkable feat of precision, the glomerular capillary wall allows water and
small solutes to pass readily into Bowman’s space whule rejecting albumin and
other large proteins with great efficiency. In its entirety, this meticulous engine of
ultrafiltration is composed of three noteworthy parts- endothelial ceils,
extracellular basement membrane, and epithelial ceils (Figure 1).
FIGURE 1: The glomerular wall. Electron micrograph of the glomerular wall
of tissues fixed in osmium and embedded in Epon. Endothelium (END) and
podocytes (P) flank the glomerular basement membrane (GBM) which together
make up the filtration barrier to the blood plasma. The filtrate moves from the
capillary lumen (CL) and into the urinary space (US) by way of the sut
diaphragms at the junction of GBM and podocytes. X40 000 (Courtesy of I.
Londo?io)
5Endothelium
The endothelium of glomerular blood capillary vessels represents the first
physical barrier in blood filtration. The most salient feature of this endothelial
layer is the presence of fenestrae that are relatively large in size (50-100 nm) and
are open, that is, lack the usual diaphragms that are present in other fenestrated
capillaries (Farquhar, 1991). Whule it may seem like these large open windows
offer littie or no resistance to the passage of blood plasma, recent evidence
emphatically argues that heavily fenestrated endothelial ceils are important
elements of the highly permselective glomerular barrier (Haraldsson and
Sirensson, 2004). Admittedly, the actual fenestrae are too large to effectively
sieve macromolecules (Deen, 2004), but the celi coat or glycocalyx secreted by
endotheliaÏ ceils themseÏves lias been under recent scrutiny for its potential size
and charge-selective properties (Haraldsson and Srensson, 2004). To date it lias
been established that this layer coating endothelial celi surfaces is made up of
glycosaminoglycans and proteoglycans in combination with plasma proteins, but
further investigations on its composition and turnover rate are needed before
defining its precise role in glomerniar permselectivity (Haraldsson and S6rensson,
2004). One well-established fact, however, is the presence of the negatively
charged protein podocalyxin at the ceil surface of endothelial ceils (Dekan et al.,
1991; Kerjaschki et al., 1984; Latta et al., 1975). Podocalyxin reportedly pushes
away other negatively charged molecules such as albumin. The fact that
endothelial fenestrae are open and larger than those of other fenestrated capillaries
makes them highly efficient for filtration, but this also renders the GBM
6vuinerable to toxic injury such as that caused by hyperglycemia in the blood, a
phenomenon we wiÏl explore in detail shortly.
Basement Membranes
The eariiest histologicai descriptions of basement membranes date back to 1857
from the laboratories of Todd and Bowman (Kefalides, 1973). In broad tenns,
basement membranes are recognized as extraceliular matrices associated with the
epithelial and endotheliai iinings of almost ail organs of the body. They are found
wherever celis (other than connective tissue ceils) meet connective tissue
(Farquhar, 1991). A century afier having identified these characteristics, great
leaps in studying tissue morphology were made with the invention of the electron
microscope and the ultrastructure of the basement membrane was described
(Kefalides, 1973). Visualization at unprecedentedly high magnifications unveiied
the lamina densa, 20-50 nm in thickness, running parallel to the basai ceil
membranes of either epithelium or endothelium, and separated from these by the
lamina lucida, a lighter, 10 nm layer (Farquhar, 1991). Histochemical studies in
the 1960s revealed the collagenous and noncollagenous glycoprotein and
proteoglycan content of basement membranes with various chemicai staining
experiments. For example, Kefalides and Denduchis (1969) used pronase on
canine basement membranes to demonstrate for the first time the overwhelming
presence of coliagen. Before that, Leblond (1957) indicated the presence of
carbohydrates with the periodic anti-Schiff reagent. Further biochemical
investigations throughout the sixties by several research groups characterised the
7complete amino acid and carbohydrate composition of basement membranes,
underlining their high content of hydroxyproÏine, glycine, and hydroxylysine as
well as glucose, galactose, fucose and mannose (Kefalides, 1973). The general
concensus is that components of basement membranes are secreted by ceils lying
adjacent and do flot differ significantly in content from organ to organ but rather
in quantity and structural organization, reflecting tissue function and specificity
(Kefalides and Denduchis, 1969). The participation of basement membranes in
processes such as tissue repair and regeneration, as weÏÏ as cellular attachment,
migration and development, has provided important insights into research on
cancer and diabetes (Erickson and Couchman, 2000; Timpi and Brown, 1996).
The Glomerular Basement Membrane
An extensively studied and long-time favorite of basement membrane-aficionados
is the highly specialized basement membrane of the glomerular capillaries of
mammalian kidneys. Pioneering the ultrastructural description of the glomerular
basement membrane under electron microscopy were Rhodin (1955), Yamada
(1955), Kurtz and McManus (1959), and farquhar (1960) among others. Their
ground-breaking studies paved the way for more involved histochemical and
biochemical analyses of the glomerular basement membrane, analyses that
eventually ascribed it its two main functions of support and selective filtration
(Kefalides, 1973).
8The glomerular basement membrane bears certain distinguishing features that sets
it apart from other basement membranes. It is thicker (350 nm in humans) and
more compact, it is formed by fusion of endothelial and epithelial basement
membranes, and it faces endothelial and epithelial celi layers on both surfaces
(Farquhar, 1991; Desjardins and Bendayan, 1991). The particular structure
fiinction relationship of the glomerular basement membrane in relation to other
extracellular matrices was well defined. Desjardins et al. demonstrated that the
specific spatial distributions of the main components of the GBM were
instrumental in detemiining its filtration properties. This was done by showing
how the passage of albumin is increasingly restricted to the subendothelial layer
as maturation ofthe GBM progresses (Desjardins and Bendayan, 1991; Bendayan
et al., 1986). It has thus become dogma that the structural and chemical
composition of the mature glomerular basement membrane is what renders it its
unique filtration properties.
Throughout the 1970s, the works of Spiro and Kefalides with purified GBM
fractions provided a great wealth of information on the fine architecture of the
glomerular basement membrane (Farquhar, 1991). The 1980s ushered in the era
of immunolabeling in electron microscopy which also proved to be a valuable tool
in elucidating not only the content but also the distribution of GBM constituents
(Courtoy et al., 1982; Stow et al., 1985; Kerjaschki et al., 1986). This was done
through the purification of proteins from renal glomeruli and tubules which were
then used as antigens to prepare specific antibodies (Kerjaschki et al., 1986). The
9culmination of this work, mostly carried out in Farquhar’s laboratory, revealed
that the major components of the GBM are collagen type W, laminin, lieparan
sulfate proteoglycan, nidogen or entactin, and BM4O (farquhar, 1991). Electron
microscopy uncovered specific pattems of distribution of collagenous
components, proteoglycans and glycoproteins in laminae rarae and laminae
densae, eventually leading to sophisticated three-dimensional models of
glomentiar basement membrane architecture. The sturdy scaffolding networks
created from the binding affinities existing between type-IV collagen, heparan
sulfate, laminin, nidogen and entactin underlines the basement membrane’ s tough
supportive qualities (farquhar, 1991).
The highly selective filtering properties of the GBM are dependent on the quality,
the quantity, and the distribution of its constituents. Increasingly sophisticated
physiological blood plasma clearance studies have demonstrated that the
glomerular basement membrane serves primarily as a charge- and size-selective
barrier (farquhar, 1991). for example, the presence ofhighly negatively charged
regions of glycosaminoglycans containing heparan sulfate impose a significant
charge barrier (Farquhar, 1991), conferring them the role ofthe main anionic site
for GBM charge selectivity (Akthar, 2004). It lias been speculated that the size
selective sieving properties of the GBM are a property of the highly compact
meshwork of type-W collagen (Kanwar, 1984). Collagen is composed of three
alpha-chains forming triple-helical molecules, which form a tightly cross-linked
network structure. It is chiefly concentrated in the lamina densa of the GBM
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(Kanwar, 1984). Although the exact size of the pores formed by networks of
collagen and other GBM proteins have flot been precisely determined, it is widely
accepted that size restriction is an inherent quality of the highly specialized
meshwork ofthe GBM. Morphological approaches using the large (60 À) ferritin
molecule as a tracer revealed that much of the size-selection occurs at the level of
the lamina rara interna (Farquhar et al., 1961) while smaller molecules like
horseradish peroxidase can traverse the membrane (Kefalides, 1973). The
significance of the GBM as an important size-barrier was also highlighted by
farquhar in an experiment involving dextran tracer molecules (farquhar, 1975), a
finding which actually shified the attention of the primary filtration barrier from
podocytes to the GBM. Albumin lias also played a central role in identifying the
specific size retention areas in the glomerular basement membrane (Bendayan et
al., 1986; Londoflo et al., 2003). Immunocytochemistry revealed the presence of
albumin at the level of the endothelial celi basal plasma membrane and on the
subendothelial side of the lamina densa of the GBM, indicating that albumin
retention occurs at these sites (Bendayan et al., 1986). following up on these
experiments, it was shown that glycated albumin, once in circulation, penetrates
the glomerular wall of normal animais deeper than nonglycated albumin and
eventualiy reaches the urinary space. This provided evidence that albumin
normally does not pass through the glomerular wall while an abnormai glycated
version ofthe protein is able to modify the glomerular filtration properties in such
a way as to be able to reach the urinary space (Londoflo et al., 2003).
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Podocytes
The epithelial ceils of the glomerular wall are called podocytes which separate the
endothelial capillary vessels from the urinary space ofthe Bowman’s capsule. In
scanning electron microscopy it is possible to visualize their unique cell body
prolongations which resemble interlacing fingers covering the entire surface area
of capillary vessels (Guyton and Hall, 2000; Tisher and Madsen, 1986). from
these elongations emerge smaller secondary projections called pedicels. Pedicels
interdigitate with other pedicels from neiglibouring podocytes and firmly anchor
themselves in the lamina rara externa of the GBM (Tisher and Madsen, 1986;
Pihiajaniemi, 1996). It is interesting to note that adjacent pedicels are most likely
projections from different podocytic cell bodies (Tisher and Madsen, 1986).
The podocytes are the most voluminous cells in the glomerulus (Guyton and Hall,
2000). Along with a well-developed Golgi, they contain free ribosomes as well as
rough and smooth ER cistemae (Tisher and Madsen, 1986), which indicates their
marked propensity for protein synthesis. Kurtz and feldman (1962) pointed out
that podocytes are largely responsible for the biosynthesis of the glomerular
basement membrane. In fact, it has been widely documented that enzymes
responsible not only for GBM synthesis but also turnover and maintenance, are
largely synthesized within podocytic ce!! bodies (Lee et al., 1993; McCarthy,
1997). 0f these enzymes, the family of matrix metalloproteases play a crucial
role as will be seen shortly.
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In the past decade, attention has been shifted to podocytes for a clearer
understanding of permselectivity. The spaces existing between pedicel
interdigitations vary between 25 and 60 nm and are called filtration siits
(Pihiajaniemi, 1996), while the porous thin membranes that traverse the filtration
slits are called sut diaphragms (Leeson and Leeson, 1981). The sut diaphragms
of adjacent pedicels are linked to each other by specialized plasma membrane
adherens junctions (Guyton and Hall, 2000; Tisher and Madsen, 1986), and the
integrity of this arrangement is largely dictated by the presence of a sialic acid
rich glycocalyx (Farquhar, 1991).
It was long believed that the primary filtration barrier of the glomerular wall
resided in the filtration sut regions ofpodocytic interdigitations. Jndeed, this area
was shown to exhibit size-restrictive properties (Rodewald and Kamovsky, 1974),
and is also essential for glomerular wall reinforcement in the face of high
hydrostatic blood plasma pressures (Keijaschki, 2001). It is only with the recent
molecular era that our understanding of podocytes and their role in filtration has
greatly advanced. Kerjaschki greatly facilitated our comprehension of the
increasingly complex molecular characteristics of the podocytes by separating its
plasma membrane area in three distinct microdomains: the sut diaphragms at the
junction of adjacent podocytes, the basal membrane which touches the GBM, and
the apical membrane.
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Sut Diaphragm
The most influential study ofthe fine structure ofthe sut diaphragm was provided
by Rodewald and Kamovsky back in 1974 (Rodewald and Kamovsky, 1974).
They interpreted electron microscopy images of sut diaphragms as zipper-like
structures that are arranged in sucli a way to restrict passage of molecules. The
zipper resembles a central dense region with openings roughly the size of albumin
(Deen, 2000). The novel application of electron tomography was able to show an
increased complexity of the pores, more tortuous and irregular than previously
supposed (Deen, 2000). Characterization of the molecular composition of slit
diaphragms boomed in recent years with the identification of nephrin (HoÏzman et
al., 1999; Kerjaschki, 2001), NEPH-1 (Keijaschki, 2001), CD2AP (Keijaschki,
2001; Li et al., 2000), and podocin (Keijaschki, 2001; Schwarz et al., 2001). The
newly discovered protein that received the most attention was the
transmembranous nephrin, found to be an adhesion protein necessary for the
formation ofjunctions (Holzman et al., 1999; Kerjaschki, 2001). It was recently
demonstrated that the fibers constituting the slit diaphragm appear to be formed
largely by the association of extracellular strands of nephrin (Deen, 2000). The
exact mechanism by which nephrin controls permselectivity is not yet clear but
the Finnish congenital nephrotic syndrome emphasized the importance of nephrin
which is absent in this disease (Akthar, 2004). Tiideed, in nephrin-knockout mice,
ordered slit diaphragm structures are no longer evident, and proteinuria resuits
(Deen, 2000). Increasing evidence only ftirther confirms that disruption ofthe sut
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diaphragms is sufficient to cause abnormal loss of proteins in the urinary space
(Hamano et al., 2002).
Basal Membrane
The basal plasma membrane of podocytes is anchored to the GBM through
adhesion proteins, most notably integrin a331 (Kerjaschki et al., 1989). a3t31
bridges podocytes and GBM through association with paxillin, talin and vinculin
on the cytoplasmic podocytic side (Drenckhahn and Francke, 1988), and collagen,
fibronectin, laminin and entactin on the GBM extracellular matrix side (Kretzler,
2002). Another noteworthy constituent of the podocyte basal membrane is
dystroglycan which is believed to regulate the position and spacing of proteins in
the extracellular matrix. This would confer it a role in porosity and GBM
permeability. Indeed, a fali in dystroglycan expression has been shown to
coincide with podocyte effacement and proteinuria (Kerjaschki, 2001).
Apical Membrane
The main role of the apical membrane region of podocytes seems to be in the
maintenance of structure and cohesion of podocytes (Kerjaschki, 2001). This
function has been linked to the presence of podocalyxin, a highly negativeÏy
charged protein also present on the endothelium, as was mentioned earlier. This
glycoprotein was found to be abundant on the apical surface of podocytes by
Sawada et al. in 1986 who also discovered that neutralizing the charges on
podocalyxin leads to alterations in podocytic processes and slit diaphragm
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organisation, a finding which underlines the importance of its presence in
podocyte maturation. Recent evidence also indicates that podocalyxin can also
link itself to cytoskeletal actin by virtue of NHERV-2 and ezrin (Kerjaschki,
2001), which confers to podocyte projections their particular “feet”-like
architecture.
Together, the endothelium, glomerular basement membrane and podocytes
interact to foi-m an highly intricate sieve designed to select molecules on the basis
of size, shape and charge. Despite the comprehensive and compelling evidence
offered on the structural and biochemical composition of the glomerular wall, the
specifics of ultrafiltration stiil remain nebulous. Initially it was widely believed
that the primary filtration barrier was located exclusively at the interdigitations of
podocytes (Kamovsky and Ainsworth, 1972) but Bendayan and farquhar
produced persuasive evidence highlighting the size-restrictive properties of the
glomerular basement membrane (farquhar, 1975; Bendayan et al., 1986).
Recently, more weight has been given to the epithelial sut diaphragms due to
important advances in molecular biology and the identification of nephrin. A
comprehensive study has shown how decreased expression of nephrin correlates
with a loss in glomerular filtration integrity (Hamano et al., 2002). finally, in
2004, S5rensson and Haraldsson argued that too much attention has been given to
the GBM and epithelial podocytes in particular, while the endothelium probably
has a much greater role in glomerular permselectivity than we believe. This is in
light of new information conceming the cell surface coat covering endothelial
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ceils called the glycocalyx, and the identification ofproteins within it that seem to
be of vital importance for capillar permeability (S5rensson and Haraldsson, 2004).
The debate rages on, yet one thing remains certain: the proper functioning of the
glomerural wall is a function of the integrity, interdependence, and proper
communication of ail its parts.
Diabetic nephropathy
Whether we like it or flot, our understanding of how something works is greatly
advanced when that thing doesn’t work. Such is the case with the glomemiar
filtration apparatus; rnuch of our knowledge of its function cornes from
observation of pathophysiological situations which surround glomerulosclerosis.
Malfunctioning as a resuit of diabetes leads to generalized proteinuria or
abnormal loss of proteins into the urinary space due to an imbalance in the size
and charge-selective barrier properties of the glomerular wall. The relevance of
diabetes mellitus in today’s society cannot be overemphasized: there is a 2-5%
increase in the incidence of type-I diabetes but the real concem is the global
increase in type-II, largely due to childhood obesity (Silink, 2002). Diabetic
nephropathy, a condition that develops afler exposures of tissues to chronic
hyperglycemia, is one of the leading causes of renal failure in Western countries
(Mason and Wahab, 2003). Diabetic patients account for nearly haif of ah
patients on haemodialysis, the kidneys being home to the gravest
pathophysiological consequences of this disease (Del Prete et al., 1998). The
complications arising from these lesions lead to glomerular fibrosis which
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progressively destroys the renal filtration unit and may eventually cause renal
failure (Del Prete et al., 1998). Our project deals specifically with changes,
structural and compositional, in the glomerular wall at the molecular level that
accompany the onset ofthis devastating disease.
As early as 1959, morphological changes ofthe glomerulus in diabetic conditions
were observed by electron and light microscopy (farquhar et al., 1959). Studies
by several different groups concurred that the most striking feature of a
glomerular wall exposed to an hyperglycemic environment is the significant
thickening of the glomerular basement membrane (Figure 2) (Kimmelstiel et al.,
1962; Bloodworth, 1963; Østerby and Lundbaeck, 1970). Further investigations
into this morphological discrepancy revealed an important correlation between
GBM thickening and biochemical changes in the amino acid and sugar
composition ofthe basement membrane (Spiro and Spiro, 1968; Beisswenger and
Spiro, 1970; 1973; Beisswenger, 1976; Spiro, 1976). Pioneering work conceming
the effect of diabetes on the biochemical composition of the basement membrane
was thus undertaken. Kanwar demonstrated by autoradiography and biochemical
analysis that proteoglycan synthesis decreased by 40% in diabetic rats relative to
normal rats (Kanwar et aI., 1983). In an elegant experiment employing
glucosyltransferase, an enzyme involved in the synthesis of certain GBM
components, Spiro and Spiro demonstrated increased levels of this signaling
protein in diabetic kidneys relative to normal ones (Spiro and Spiro, 1971).
Indicating that increased basement membrane synthesis in diabetes might be a
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resuit of the overexpression of this protein, they also noted that this process is
reversible through insulin administration. Additional studies signaled the effect
of diabetes on the metabolism of the GBM, as well as the significantly reduced
level of heparan sulfate, the aforementioned major player enforcing charge
selectivity, in the GBM under diabetic conditions (Parthasarathy and Spiro, 1982;
Brownlee and Spiro, 1979). Employing ultrastructural analyses, other studies also
confirmed a decrease in heparan sulfate immunolabeling in the lamina rara
interna of the GBM in diabetic rats (Desjardins and Bendayan, 1990; Vemier et
al, 1992).
While Spiro focused on biochemical modifications, the works of Østerby for the
past three decades were instrumental in elucidating those structural changes that
characterise glomerulopathy (Østerby and Gundersen, 1980; Gundersen and
f •1., -
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FIGURE 2: Comparison between gtomerular walls of normal and diabetïc
animais. Electron micrograph of glomerular walls of rat renal tissues, 2-month
old control (CTL) and 6-month old diabetic (STZ) animals. Significant
thickening is observed in the glomerular basement membrane of the diabetic
animal due to increased deposition of extracellular matrix components. X60 000
(Courtesy of T. Londoflo)
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Østerby, 1977; Østerby et al., 1993; Østerby et al., 1987; Østerby et al., 1988).
Using streptozotocin-induced diabetes in rats, it was shown that generalized
glomerular enlargement was apparent only four days afler injection (Østerby and
Gundersen, 1980). Progressive expansion of the mesangial matrix, and
thickening of the glomerular and tubular basement membranes thus became
universal hallmarks of human and experimental diabetic nephropathy (Del Prete
et al., 1998). These findings provided the firm basis upon which countless
experiments were inspired to supply additional information on the characteristics
of diabetic nephropathy.
The technique of high-resolution immunocytochemistry using electron
microscopy and immuno-biochemical quantifications offered great insights into
the expression and distribution of structural proteins in the GBM. In diabetic
patients with only mild glomerulosclerosis, increases in collagens type-W, ai, a2,
cr3 and cr4, laminin, and fibronectin were reported while levels of perlecan
decreased (Kim et al., 1991; Mohan et al., 1990; Shimohura and Spiro, 1987).
Other factors found to be abundant in glomerular diabetic tissues were advanced
glycated end products (Gugliucci and Bendayan, 1996; Bendayan, 1998). The
main cuiprit ofbasement membrane expansion, however, is the high deposition of
collagen. Increases in collagen deposition in GBM and mesangial matrix (Regoli
et al., 1998; Nerlich et al., 1994) as well as an augmentation in collagen mRNA
(Park et al., 1997; Fukui et al., 1992) have been well documented in advanced
diabetic tissues. Desjardins and Bendayan brought to our attention the
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modification in the spatial distribution of collagen type-W in fong-term diabetic
animais (Desjardins and Bendayan, 1990). Normaliy concentrated in the lamina
densa, collagen type-W was found to be relocalized to the subendothelial side of
the GBM in diabetic animais (Bendayan, 1985; Desjardins and Bendayan, 1990).
No changes were observed in the distributions of laminin, entactin and heparan
sulfate in those same animais (Desjardins and Bendayan, 1990). It thus became
apparent that any modifications conceming the expression and distribution of
structural proteins in the GBM were reflected in the three-dimensional scaffolding
networks. lndeed, through immunocytochemistry in electron microscopy, it was
possible to observe an alteration at the level of structural organisation of GBM
components during the course ofdiabetes. Specificaliy, the endothelial side ofthe
GBM gave rise to dense bundles of fibrils identified as basotubuies which were
found to be iargeiy associated with type-W coilagen in diabetic animais (moue
and Bendayan, 1995).
Our project focuses on specific factors leading to the occurrence of the most
prominent morphologicai feature of giomeruiopathy: the thickening of the
giomerular basement membrane, a phenomenon which has been associated with a
decrease in filtration area, abnormal loss of proteins in the urinary space and
ultimately end-stage renai failure. With this important observation, it became
apparent that perpetual maintenance and turnover of the molecules that make up
the giomeruiar basement membrane is sine qua none for proper permseiectivity.
It is now widely accepted that the amount and composition of the GBM
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extraceliular matrix relies on the delicate interactions existing between synthetic
and degradative pathways, and that various forms of giornerular diseases are
characterized by shifts in this balance.
Membrane Type-I Metalloprotease
Nowadays, when someone says “tissue remodeling”, the matrix metalloproteases
(MMP5) imrnediateiy corne to mmd (well, arnong us molecular biologists
anyway). This growing famiiy of zinc-dependent metalloendopeptidases is the
object of rnany studies dealing with extraceliular rnatrix turnover. This is due to
their prominent role as cleavers of practically ail components of the extracellular
matrix such as collagen, proteoglycans, fibronectin, and larninin (Bode et al.,
1999). MMPs have thus been shown to be key players in processes involving
degradation of pericellular proteins, thereby assurning pivotai roles in normal and
pathological processes (Stemlicht and Werb, 2001).
Historically, MMPs were classified as collagenases, gelatinases, stromelysins, and
rnatrilysins based on their cleaving specificities, but the growing number ofMMP
substrates has prompted us to group them according to structure (Egeblad and
Werb, 2002). The 21 MMPs are divided into eight structural classes; five
secreted and three membrane-type MMPs (Egeblad and Werb, 2002). The
degradative functions of metalloproteases are iargeiy kept in check by their
endogenous tissue inhibitors (TIMPs) and disrnption of this balance has been
documented to resuit in serious diseases such as arthritis, turnor growth and
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metastasis (Bode et al., 1999). Thus MMPs are abie to regulate many biological
processes and are closely regulated themselves.
MMPs share several structural and functional properties: they are synthesized as
inactive zymogens containing a secretory signal sequence, a propeptide hinge, as
well as hemopexin-like and catalytic zinc-binding domains (Lenz et al., 2000;
Stamenkovic, 2003). Activation requires proteolytic removal of the propeptide
prodomain (Egeblad and Werb, 2002). 0f the currently known MMPs, MMP-1,
MMP-13, MMP-3, MMP-2, MMP-9, and MT1-MMP ail share the characteristic
of being collagenases and thus have been extensively studied in the glomerulus
(Lenz et al., 2000). In this project, we chose to study the membrane type-I matrix
metalloprotease (MT1-MMP) due to its unique properties conferred by its
location at the cellular membrane.
The membrane type-I metalloprotease distinguishes itself as a membrane-bound
enzyme capable of exerting its cleavage activities from the vantage point of the
celi surface (Bode et al., 1999). MT1-MMP possesses an additional stretch of
around 20 hydrophobic amino constituting a transmembrane domain, followed by
a short cytoplasmic tau (Figure 3) ($ato et al., 1994). Active MT1-MMP inserts
itself into the plasma membrane with the catalytic domain facing the extracellular
space, where it can cleave substrates in the extracellular matrix (Osenkowski et
al., 2004). Localization of MT1-MMP at the ceil membrane is perfect for
pericellular proteolysis allowing for a new set of substrate targets, distinctive
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interactions with T1MPs and a non-conventional mechanism of regulation
involving enzyme intemalization, processing and ectodomain shedding (Toth et
al., 2002; Osenkowski et al., 2004).
MOPl3
FIGURE 3: Domain structure of MI1-MMP. Signal sequence (PRE),
propeptide (PRO) with a free zinc-ligating thiol (5H) group, furin-susceptible site
(F), zinc-binding site (Zn), hinge region (H), transmembrane region (TM), and
cytoplasmic tau (C). The hemopexin domain contains four repeats, the first and
last are linked by a disulfide bond. (Illustration not to scale by Emmanuelle
Boucher, adapted ftom Sternlicht and Werb, 2001: How matrix
metalloproteinases regulate ccli behavior. Ann Rev Ceit Dey Bio! 17: 463-5 16)
Current evidence indicates that MT1-MMP is able to regulate matrix turnover due
to its ability to degrade matrix-associated molecules, either directly or via
activation of downstream MMPs (Yana and Weiss, 2000). The dual role of Mil
MMP as activator of other MMPs capable of initiating activation of zymogen
cascades, and as direct cleaver of ECM components, only underscores its vital
function as an extracellular matrix remodeler and singles it out as a potential
therapeutic target (Lenz et al., 2000; Ohuchi et al., 1997). The importance of
MT1-MMP’s role as a collagenase was demonstrated in mice deficient in Mil
MMP which suffered severe complications in remodeling of skeletal connective
tissues, resulting in earlier death (Holmbeck et al., 1999). It has been speculated
that MT1-MMP’s strategic location confers it an advantage over other
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collagenases in that it can accornplish localized and efficient collagen degradation
at the celi surface (Hotary et al., 2000), as well as initiate zymogen activation
cascades (Toth et al., 2003). One such cascade is the activation of pro-MMP-2
which was actually the mechanism by which MT1-MMP was first identified
(Overail and LopezOtin, 2002). Here, active MT1-MMP binds TIMP-2 which
generates a surface receptor for pro-MMP-2 (Osenkowski et al., 2004). The
resulting MT 1 -MMP/TIMP-2/pro-MMP-2 ternary complex presents the bound
pro-MMP-2 to a neighbouring TTMP-2-free MT1-MMP which will initiate the
activation of pro-MMP-2. Once proteolytically processed by MT1-MMP, active
MMP-2 is released into the extracellular space where it can carry out its cleavage
activities (Bemardo and Fridman, 2003). This effectively changed our traditional
view of TJMPs as inhibitors to that of versatile molecules capable of acting in the
promotion ofpericellular proteolysis. Indeed, MT1-MMP plays a dual role in the
pathophysiological digestion of extracellular matrix through direct cleavage of the
substrates and the indirect activation of pro-MMP-2 as well as other zymogen
cascades (Coweil et al., 1998; Toth et al., 2003). MT1-MMP’s wide substrate
range specificity includes collagen types I, II and III (into typical 3/4 and Y4 length
fragments), laminin types 1 and 5, vitronectin, gelatin, proteoglycan fibrin, and
aggrecan (Ohuchi et al., 1997). It is thus evident that appropriate expression and
activity of this endoprotease is a mainstay for basement membrane maintenance
and turnover.
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Furin
As mentionned earlier, cleavage of the propeptide region is essential for MT1-
MMP activation and subsequent proteolytic activity. Yana and Weiss
demonstrated the existence of a proprotein convertase-MT1-MMP axis allowing
for the unmasking of MT1-MMP’s catalytic domain and conversion into a
catalytically active species (Yana and Weiss, 2000). This was done through the
identification of the RX(KIR)R basic motif in the propeptide region of MT1-
MMP, a sequence of amino acids that can potentially be recognized by the
proprotein convertase family of subtilisin-like proteases. Jndeed in vitro studies
using MT1-MMP deletion mutants confirmed that furin is capable of cleaving the
proMTl-MMP zymogen (Yana and Weiss, 2000). It is thus apparent that
cooperative interactions between proprotein convertases and membrane-anchored
MMP’s play an important role in regulating the remodeling ofECM.
furin is a caïcium-dependent endoprotease involved in the proteolytic activation
of a large variety of proprotein substrates in secretory pathway compartments
(Thomas, 2002). The importance of furin as a proprotein convertase capable of
processing a wide range of precursors cannot be overemphasized as it has been
shown to be ubiquitous in most ceil types (Blanchette et al., 1997). Also,
knockout of furin gene is embryonic lethal (Roebreck et al., 199$), underlining its
importance in the maturation, function and activation of several hormones, growth
factors, and ceil surface receptors (Molloy et al., 1999). Specific amino acid
motifs identified in furin’s cytoplasmic tau have shown to target furin to different
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cellular compartments; a finding which has shed light on furin trafficking between
the trans-Golgi network, endosomal compartments and the ceil surface (Plaimauer
et al., 2001; Molloy et al., 1994; Mayer et al., 2003).
The physiological role of furin in glomerular celis was well characterized by
Mayer et al.. Double immunogold labelings revealed that furin was co-localized
along with pro-MT1-MMP in the biosynthetic pathway, and was also observed
beyond the trans-Golgi network and on the cell surface of podocytes (Mayer et
al., 2003). Mayer et al. propose an MT1-MMP/furin activation axis at podocytic
and endothelial abluminal membranes facing the GBM for a type of focalized
pericellular proteolysis essential for GBM turnover (Mayer et al., 2003). These
novel findings on the cellular biology of podocytes prompted us to investigate
whether the expression of these proteins was altered in a hyperglycemic
environment. This would shed some light on the elements that characterize the
integrated functions of cellular and extracellular elements involved in tissue
remodeling, and their disregulation in diabetes.
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Objective of $tudy
The aim of our project is to characterize some specific molecular changes in the
glomerular wall that accompany diabetic glomerulosclerosis. The possibility that
the expression andlor localization of proteins involved in extracellular matrix
turnover is modified is highly suggested by the thickening of the glomerular
basement membrane. This is why the membrane type-I matrix metalloprotease,
one such endoprotease involved in the cleaving of many ECM components, and
its activating enzyme furin, were elected for study. It was decided that valuable
comparisons couid be made between short- and long-term diabetic animais and
their age-matched controls. Rats were thus injected with streptozotocin and
sacrificed afler 2 and 12 months of maintaining a hyperglycemic state.
Comparitive evaluations could then be undertaken at a morphological and
biochemical level.
Immunocytochemical techniques with colloidal gold immunolabeling offer
distinct advantages in evaluating these enzymes’ expression and localization in
the renal tissues of normal and diabetic animais. Antigenic sites of MTY-MMP
and furin can be detected with their corresponding polyclonal antibodies which in
mm can be revealed by the protein-A colloidai gold complex (Bendayan, 1995).
This high resolution technique flot only allows us to view the localizations of
MT1-MMP and fiirin, but also to quantify their intensity in labeling.
2$
Morphometncal analyses were greatly facilitated by virtual dissection of the
glomerular wall into distinctive structures (Figure 4). It is thus possible to
quantitatively evaluate selected portions of glomerular cell surfaces suspected to
harbor these matrix-remodeling enzymes.
- —e-
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FIGURE 4: Dïssected areas of the glomerular walI for morphometrical
evaluation. The plasma membrane surfaces of the glomerular wall were virtually
separated into five distinct regions to facilitate morphometncal analysis: the
abluminal (red) and luminal (green) podocyte membranes, the sut diaphragm
(blue), and the abluminal (yellow) and luminal (pink) endothelial membranes.
Gold particles per micrometer were measured. X40 000 (Courtesy of I. Londoflo)
To further substantiate immunocytochemical data, we perform western blots on
glomerular lysates, once again using polyclonal antibodies against MT1-MMP
‘4:
and ftirin. When discrepancies were observed between biochemical and
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morphological resuits, immunocytochemistry once again proved to be an
invaluable tool in resolving these inconsistencies by revealing changes in
localization of the studied enzymes within the glomerular wall. The western
blotting and immunogold techniques thus complement each other well, rendering
it possible to determine overall expression and specific placement of proteins in
the glomerular wall.
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ABSTRACT
Diabetic glomerulopathy has been linked to shifts in balance between the
synthetic and degradative pathways of the glomerular basement membrane, a key
player in the permselectivity of macromolecules. The goal of this study was to
trace the expression and localization of MT1-MMP and its activating enzyme
fin-in, key proteins involved in basement membrane turnover, in short and long
term diabetic rat renal tissues.
Quantitative immunogold was carried out for MT1-MMP and finin and their
expression was evaluated in renal tissues of young and old, control and diabetic
rats. To corroborate immunocytochemical findings, western blots were
performed on glomerular lysates.
Electron microscopy revealed that the overali expression of MT 1 -MMP and furin
is reduced in plasma membranes of celis of old normoglycemic animais, a
phenomenon that is exacerbated in long-terni diabetic animais. This observation
supports the prevailing theory that diabetes fosters an acceleration in the aging
process. Interestingly, while biochemical resuits confirmed a decrease in Mil
MMP expression, an increase in furin was observed.
Immunocytochemical studies resolved this discrepancy by tracing the increased
furin expression in ER and Golgi membranes of podocytes, indicating that furin
miglit be retained in the secretory pathway in a diabetic environment.
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Disturbances at the moledular level of the otherwise tightly regulated MT1-
MMP/furin interactions found at the ceil surface must account for a lack in
extracellular matrix remodeling, increased deposition of GBM material, and loss
of glomerular filtration integrity.
Key words: diabetes, glomemiosclerosis, MT1-MMP, furin, GBM turnover
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INTRODUCTION
As the ultimate site of plasma filtration, the glomerular wall plays a vital role in
maintaining proper permeability for the production of primary urine (1). The
integrity of the glomerular wall in terms of structural organization and protein
composition is the comerstone of intact permselectivity. Obvious morphological
changes associated with the onset of diabetes and loss of permselectivity include
thickening of the glomerular basement membrane (GBM), expansion of the
mesangial matrix, and podocyte effacement (2-4). The molecular era of the past
two decades has allowed us to witness a wave of information conceming the
proteinacious composition of the main filtrating constituents of the glomerular
wall, notably the endothelial fenestrations, the GBM, the sut diaphragms at the
junction ofpodocytes, and the mesangial matrix (1,5-6). It has thus recently been
possible to identify the molecular mechanisms responsible for progressive
glomerulosclerosis at an ultrastructural level.
Electron microscopy employing the immunogold technique as an investigative
tool has played an essential role tracing the modifications in molecular
composition of glomerular wall components in hyperglycemic environments (7-
12). Desjardins et al. in particular, followed the expression and localization of
certain key molecular constituents of the GBM and reported that while most
molecules remained intact, there were changes in type W collagen distribution
and expression in diabetic rats (12,13). Indeed the importance of collagen
deposition and accumulation in the thickening of the GBM cannot be
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overemphasized (5,14-15). One of the consequences was a race to identify and
locate the enzymes responsible for basement membrane turnover, a process which
proves integral to the maintenance of intact glomerular filtration. We then came
to realize that the amount and composition of extracellular matrix depends on the
delicate interactions existing between synthetic and degradative pathways, and
that various forms of glomerular disease are characterized by shifis in this balance
(16-17).
The matrix metalloproteases are a large family of zinc endopeptidases widely
recognized as crucial mediators in extracellular matrix turnover (18). The
membrane type-I metalloprotease distinguishes itself as a membrane-bound
enzyme capable of exerting its cleavage activities from the vantage point of the
celi surface (19). Osenkwoski et al. underline the regulatory benefits of Mil
MMP’s strategic positioning at the membrane. Localization of MT1-MMP at the
celi membrane is perfect for pericellular proteolysis allowing for a new set of
substrate targets, distinctive interactions with TIMPs and a non-conventional
mechanism of regulation involving enzyme internalization, processing and
ectodomain shedding (20-2 1).
The primary function of MT1-MMP is to degrade matrix-associated molecules
either directly or via the activation of downstream MMPs (22). Animal
knockouts have shown that MT1-MMP is the only MMP known to be essential
for suwival (20), a fact that is emphasized by its wide array of substrates (22).
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The dual role of MT1-MMP as activator of other MMPs capable of initiating
activation of zymogen cascades, and as direct cleaver of ECM components, only
underscores its vital function as an extracellular matrix remodeler and singles it
out as a potential therapeutic target (17,22).
Cleavage of the propeptide region is sine qua non for MT1-MMP activation and
subsequent proteolytic activity. Yana and Weiss demonstrated the existence of a
proprotein convertase-MT1-MMP axis allowing for the unmasking of MT1-
MMP’s catalytic domain and conversion into a catalytically active species (23).
This was done through the identification of the RX(K!R)R basic motif in the
propeptide region of MT1-MMP, a sequence of amino acids that can potentially
be recognized by the proprotein convertase family of subtilisin-like proteases.
Jndeed in vitro studies using MT1-MMP deletion mutants confirmed that furin is
capable of cleaving the proMTl-MMP zymogen (23). It is thus apparent that
cooperative interactions between proprotein convertases and membrane-anchored
MMP’s play an important role in regulating the remodeling ofECM.
Furin is an endoprotease involved in the proteolytic activation of a large variety of
proprotein substrates in secretory pathway compartments (24). The importance of
furin as a proprotein convertase capable of processing a wide range of precursors
cannot be overemphasized as it has been shown to be ubiquitous in most celi
types (25). Specific amino acid motifs identified in furin’s cytoplasmic tail have
shown to target furin to different cellular compartments; a finding which has shed
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light on furin trafficking between the trans-Golgi network, endosomal
compartments and the celi surface (26-28). The physiological role of furin in
glomerular celis was well characterized by Mayer et al. who co-localized the
protein with pro-MT1-MMP in the biosynthetic pathway and traced their
transiocation beyond the trans-Golgi network onto the celi surface (28). Mayer et
al. propose an MT1-MMP activation axis at podocytic and endothelial abluminal
membranes facing the GBM for a type of focalized pericellular proteolysis which
characterizes the integrated functions of cellular and extracellular elements
involved in tissue-remodeling (28). The purpose of our study was to extend this
knowledge of interactions among ceil surface proteins mediating GBM turnover
in normal celis, to their potential modification of expression and/or deregulation
in diabetic rat renal tissues.
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RESEARCH DESIGN AND METHODS
Antibodïes
The rabbit anti-matrix metalloproteinase-14 (MMP-14 or MT1-MMP) was
obtained from Sigma-Aidrich (Oakville, ON, Canada). Raised against the N-
terminal portion of the enzyme, the antibody tags both mature and pro forms of
MT1-MMP. Rabbit anti-fin-in antibody was supplied by Alexis Biochemicals
(Axxora, LLC). The antibody was raised against the N-terminal portion (amino
acid sequence 187-198).
Animais
Experimental diabetes was induced in 150g male Sprague-Dawley rats by an
intraperitoneal streptozotocin injection (70 mg/kg body weight dissolved in 10
mM/l citrate buffer, pH 4.5). Within 48 hours, animals developed a
hyperglycemic state which lasted throughout their lifetime. Glycemia was
assessed on a monthly basis with Accu-Check test strips and blood glucose meters
(Roche Diagnostics) while glycosuria measurements were carried out weekly
using UriScan test strips (YD Diagnostics). Glycemic states at death of 2-month
and 12-month old diabetic rats averaged 25.3+4.3 and 27.4±4.0 mmolIL
respectively versus 5.6±0.8 mmol/L and 6.7±1.2 mmol/L for their age-matched
controls. Four experimental groups were created, each comprising of four
animais. Two groups were composed of streptozotocin-injected animals which
maintained hyperglycemia for 2 and 12 months, and two were their age-matched
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controls. Animais were housed and handled according to the guidelines from the
Canadian Council on Animal Care (CCAC).
Glomerular isolation
Animais were anaesthetized with urethane. Upon excision, entire kidneys were
immediateiy recovered in PBS and subjected to sequential sieving methods to
separate giomeruli (29). Isoiated glomeruli were washed and suspended in
freshiy-made lysis buffer (29), homogenized, and kept on ice for 1 hour.
Homogenates were then centriftiged (2500 rpm) for 20 min at 40 C to remove
non-soiubiiized materiai. The supematant carrying membranous proteins MT1-
MMP and furin were used for our studies. Protein quantitation was carried out
using the bicinchoninic acid method (BCA Protein Concentration Assay, Pierce)
with bovine serum aibumin as a standard. Sampies were aiiquoted at
concentrations of 40 ig and stored at 80° C untii needed.
Immunocytochemistry
SmaiÏ tissue fragments measuring 1 mm3 were rapidiy sampied from excised
kidneys and fixed by immersion in a 4% paraformaldehyde-iysine-periodate
solution for two hours at 4°C. Tissue fragments were rinsed in 0.1 mol/i
phosphate buffer, dehydrated in methanoi and embedded at -30° C in Lowicryi
K4M (30). Ultrathin sections were mounted on Parlodion-carbon-coated nickel
grids for immunocytochemistry.
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MT1-MMP and furin antigenic sites were revealed using the corresponding
polyconal antibodies in combination with the protein A-gold complex on a post
embedding immunocytochemical approach as described previously (30). The
anti-MT1-MMP was used at 1:50 and anti-furin at 1:10, both ovemight at 4°C.
Incubation with protein A-gold (10 nm) was carried out for 30 min at room
temperature. The tissue sections were stained with uranyl acetate and observed
with a Philips 41OSL electron microscope. Specificity of immunolabelings was
assessed by incubating tissue sections with the protein-A gold complex, omitting
the primary antibody step. Competition experiments were also carried out using
antigen-adsorbed antibodies.
Precise localization and quantification ofboth MT1-MMP and furin antigens over
glomerular tissue were carried out on electron micrographs with Clemex Vision
Analysis unit. Pictures were recorded at X 21 000. Forty pictures were taken for
each animal in each experimental group. The glomerular wall was
morphologically separated into 7 distinct regions for counting: abluminal and
luminal endothelial membranes, abluminal and luminal podocyte membranes, slit
diaphragm, mesangial celi plasma membrane, and glomerular basement
membrane. In addition, labelings over the rough endoplasmic reticulum and
Golgi regions of podocytes, as well as mitochondria were evaluated. The length
of these various plasma membrane domains as well as those delineating the
cellular compartments were measured and gold particles associated with these
membranes counted. Values are expressed in particles per micrometer. Mean
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values were calculated along with their standard deviations. Statistical
evaluations were carried out using the Student’s T-test.
Western blotting
Glomerular protein samples were boiled for 4 minutes in reducing SDS-sample
buffer, separated by SDS-PAGE on 10% handmade polyacrylamide gels, and then
electrophoretically transferred to nitrocellulose membranes. For MT1-MMP and
furin immunodetection, membranes were blocked in TBS (50 mM) containing
0.05% Tween 20 and 1% milk for 1 hour and 3 hours respectively, and then
incubated ovemight at 40 C with the appropriate antibodies. Antibodies were
revealed with Lumi-Light Plus chemilurninescence detection kit and resuits were
exposed with Kodak X-Omat-AR films.
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RESULIS
Under examination by electron microscopy, distinct structural features of the
renal tissue can be observed. At low magnification it is possible to view the
Bowman’s capsule surrounding the renal corpuscule composed of endothelial
cells facing the capillary lumen and epithelial podocytes facing the urinary space.
Mesangial cells are at the junction of podocytes and are embedded within the
extracellular matrix while the epithelial podocytic celi bodies project onto the
GBM. Most striking observations were podocyte effacement and pronounced
thickening ofthe GBM in tissues of 12-month oid hypergiycemic animais and to a
iesser degree in tissues of their age-matched normoglycemic animais. No
prominent morphological differences were noted between 2-month old animals,
normai as weii as diabetic.
Immunotabeting
In ail tissues, gold particles revealing membrane type-I metalloprotease antigenic
sites were found over luminal and abluminal podocyte plasma membranes, in
particular at the sut diaphragms, luminal and abluminal endothelial celi
membranes (Fig. 1), as weii as over mesangiai ceil plasma membranes. However
a specific look at the sut diaphragm region unmistakably revealed a drop in MT1-
MMP labeling from tissues of 2-month old control and diabetic rats to tissues of
their 12-month counterparts. Gold particles were seen labeling the GBM.
Labeling was virtually absent in the urinary space and capillary luminae (Fig. 1).
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Morphometrical analyses confirm subjective observations (Table 1). There is an
overall decrease in MT1-MMP labeling with age and this decline is most striking
in diabetic conditions. Number of gold particles in podocytic abluminal and
luminal plasma membranes and endothelial abluminal and luminai membranes of
old diabetic animals is significantly less than in young control animais. Overali
abiuminal and luminal podocyte membrane labelings appear to decrease by littie
less than half in tissues of old versus young animais. Similariy, there is a steady
decline in MT1-MMP labeling in the sut diaphragm regions along with age and
diabetes; 2-month oid control animals displaying the greatest number and 12-
month oid diabetic animais exhibiting less than haif that number. Labeling in the
mesangiai ceil plasma membranes of young normal and diabetic rats is quite low
but increases in old rat tissues, especially in the old diabetic ones. GBM
immunoiabelings aiso exhibit a steady increase in MT1-MMP labeling, from
young non-diabetic rat tissues to old diabetic ones. Antibody control test
measurements reveaied no significant labeling (0.0 14 ± 0.00 1 particies/Lm),
confirming the specificity of our resuits.
Furin immunoiabeiing was also found over both iuminai and abluminal
membranes of podocytes and endotheiial ceiis as well as over the mesangiai celi
plasma membranes (Fig. 2). Labeling of furin in luminal and abiuminal
endothelial plasma membranes of diabetic rat tissues seemed to be lower than in
the non-diabetic ones. There also appeared to be iess furin over luminal and
abluminai podocytic ceil plasma membranes, and in the sut diaphragm regions of
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12-month old versus 2-month old rat tissues. Furin in the glomerular wall was in
higher concentrations in luminal plasma membranes of podocytes and slit
diaphragm junctions, especially in normal rat tissues, while other analyzed
regions seemed to be more sparsely decorated. Particles were also found in
mesangial cell plasma membranes but they were few in number.
Morphometrical evaluations are in agreement with above observations (Table 2).
Gold particles numbered over one particle per micron in 2-month and 12-month
old, abluminal and luminal endothelia of control rat and decreased in diabetic age
matched counterparts. Labeling densities over abluminal and luminal podocytic
plasma membranes are considerably less in old and diabetic rat tissues when
compared to tissues of 2-month old animals. In the slit diaphragms, a two-fold
decrease occurred between young normal rats and old diabetic ones while GBM
measures oscillate within the same narrow range. Total number of gold particles
in mesangial plasma membranes remained low in both normal and diabetic
animals. Antibody control testing yield very low values (0.017 ± 0.001
particles/m) which confirms the specificity of labelings.
Westerit Btotting
Membranes incubated with anti-MT 1 -MMP revealed three bands of different
molecular weights (Fig. 3). The heaviest band at 63 kDa represents the latent
precursor proprotein before activation by cleavage (31). Bands at 57 and 44 kDa
were also observed, the former being the active and membranous version of the
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protein and the latter representing the inactive ectodomain form (20). Heavy
signaling of the 63 kDa latent precursor is seen in young, non-diabetic rat tissue
lysates. The intensity of the signal decreases sharply in samples from young
diabetic animais and nearly disappears in oid diabetic and non-diabetic ones. A
similar pattem is observed for the 57 kDa active form ofMTl-MMP. In contrast,
the 44 kDa hand signaling intensity steadiiy increases from young controi to old
diabetic animai giomerular lysates, suggesting a marked propensity for
autocatalytic degradation of the protein into its inactive form.
Western blotting of glomerular lysates reveaied a hand at 9$ kDa which
corresponds to mature rat furin (Fig. 4) (32). Only very faint signaling could be
observed in tissues of the 2-month old control and diabetic animais while denser
hands appeared in 12-month old control and diabetic rat tissue samples. This
steady signaied a discrepancy between electron microscopic observations and
biochemical resuits involving furin. This prompted us to carry on an additional
morphological investigation of the intraceliular expression of funn.
MT1-MMP and Furin in the ER and Golgi
MT1-MMP imrnunoiabeling was found over ER and Goigi membranes (Fig. 5).
There were greater amounts of gold particles in 2-month old normoglycemic and
hyperglycemic rat tissues than in their 12-month old counterparts and a
quantitative evaluation of these regions reveals a two-foid decrease in labeling
(Table 3).
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Furin immunolabeling was also found over ER membranes and Golgi cistemae of
podocytes (Fig. 6). Differences in iabeling were striking between young and old
rat tissues and morphometric countings do report a significant increase in furin
immunolabeling in 12-month old diabetic and non-diabetic rat tissues in both ER
and Golgi, when compared to the young animais (Table 4). In ail instances,
background labeling measured in neighboring mitochondria remained iow for
both antigens (Tables 3 and 4).
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DISCUSSION
This study looked to fttrther characterize the expression of some key proteins of
the giomerular waii associated with the onset of diabetes. The membrane type-I
metalloprotease and its activating enzyme furin play a pivotai role in extraceliular
matrix turnover enticing us to evaluate their expression in diabetic rat renal
tissues. By analyzing tissues of short and long terni diabetic animais, we found
that both enzymes exhibit a decrease in expression in ail evaluated plasma
membrane regions aiong with age, an aiteration that became more pronounced in
diabetic conditions. The oniy exception was the presence of extracellular MT1-
MMP within the glomerular basement membrane which actuaily increased in old
normai and diabetic rat renai tissues. These observations confirm a recurring
theme in the study of long-term diabetes, one which proposes that the presence of
diabetes accelerates the aging process (11,33-35). The consequences ofaging and
diabetes are most evidently obsewed in the thickening ofthe glomerniar basement
membrane due to increased deposition and accumulation of proteins that make up
the extracellular matrix. In the present study we found two factors which most
likely exacerbate GBM thickening: a decrease in MT1-MMP which cleaves a
wide array of ECM substrates, concomitant with a decrease in furin, a proprotein
convertase which activates MTI-MMP.
With the goal of corroborating immunocytochemical findings, western blots were
performed on glomerular iysates. Bands reveaied three different forms of MT1-
MMP; the pro and active forms significantly diminished in intensity along with
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age and diabetes as expected while the truncated inactive form increased in
signaling intensity. Furin, on the other hand, gave conflicting resuits. hstead of a
decrease in expression, as found with morphological tools, the 98 kDa furin hand
increased in intensity in old normal and diabetic rat tissues. These findings
prompted us to extend immunocytochemical investigations to the sites of
synthesis and processing ofMTl-MMP and furin.
The role of furin in pathological situations has been extensively studied (24,36-
38), yet less attention has been given to furin in normal physiological conditions.
Mayer et al. sought to reverse this trend by locaÏizing endogenous furin in normal
renal celis and thus demonstrating its potential interactions with proproteins at the
plasma membrane (28,39). Tndeed, significant pools of furin and MT1-MMP
were seen co-localized and concentrated within the Golgi apparatus of podocytic
celis as well as over plasma membranes, suggesting that transiocation of pro
MT 1 -MMP through the secretory pathway and onto the celi surface is facilitated
by fiirin. Once recruited to defined plasma membrane domains ofthe ceIl surface,
Mayer et al. propose that pro-MTY-MMP is activated by furin which allows for a
type of focalized pericellular proteolysis that could be implicated in GBM
turnover (28). Our study corroborates Mayer’s findings in normal rat renal tissue
and goes further to demonstrate the fali in both MT1-MMP and furin expression
in diabetic rat tissue. it is important to note, however, that the decrease deals only
with ceil surface membranes. The possibility that furin could stiil be residing in
4$
the Golgi and ER membranes enticed us to further our electron microscopy
investigations.
Indeed, furin immunolabeling was found concentrated over Golgi and ER
cistemae ofpodocytic ceil bodies to a greater extent in old rat renal tissues than in
their young counterparts, a trend that was more significant in diabetic conditions.
Therefore, there is a possibility that furin, although transcribed and synthesized to
a greater degree in a high glucose environment, associates with pro-MT1-MMP in
the Golgi but remains trapped in the trafficking pathway. If furin cannot shuttie
pro-MT1-MMP to the ceil surface, then it cannot activate the metalloprotease for
focalized pericellular proteolysis essential to GBM turnover.
Western blot resuits of MT1-MMP were concomitant with immunocytochemical
findings in that the active form of the protein is greatly reduced in diabetes.
Interestingly, there is a marked increase in MT1-MMP presence in the GBM of
old diabetic rat tissues suggesting a substantial rise in the shed form of the
protein. The processes of autocatalysis and shedding of MT1-MMP were
thoroughly explored by Toth et al. in an attempt to elucidate the mechanisms of
regulation governing MT1-MMP activity at the plasma membrane (21). They
observed how ectodomain shedding regulates the pericellular and extracellular
activities of MTI-MMP, allowing for either active or inactive trnncated versions
of the protein to circulate about and act on the extracellular matrix (20-2 1). This
delicate balance in enzyme activity was further layered in complexity as
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mechanisms of processing, shedding, homodimerization, and endocytosis of the
membrane metalloprotease were discovered (20). Autocatalysis ofMTl-MMP at
the ceil surface is the main mechanism behind the generation of the 44-kDa
species, an inactive degradation product lacking the catalytic domain.
Osenkowski et al. emphasize how the presence of this inactive version of the
protein can compete with the fiull-length enzyme for coliagen binding, reducing
collagenolytic activity and cellular invasion of the collagen matrix (20). The
negative influence exerted by the 44-kDa species over MT1-MMP enzyme
processing activity may explain how its overabundance in tissues of diabetic
animais, as observed in our biochemical findings, stiil slows down extracellular
matrix turnover.
In a study done in 1997, Blanchette et al. brought attention to the activation loop
between growth factor TGF- fi and furin. With the promoters regulating furin
gene expression cloned, it was possible to show in rat synovial cells incubated
with TGF- fi that this growth factor is capable of coercing furin gene promoters
into augmenting furin transcription levels (25). In a previous study, furin had
been identified as the converting enzyme responsible for generating mature TGF
fi by cleaving the R-H-R-R sequence motif (40). The resuit is an autofeedback
loop mechanism, in which TGF- fi upmoduiates fur gene expression, which in
tum increases pro-TGF- fi maturation (25). The role of TGF- fi in diabetic kidney
disease is well documented (16-17,41-43). In cells treated with high glucose
concentrations, a significant rise in TGF-fi mRNA expression is observed as early
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as 24h after the onset of hyperglycemia (16). As a resuit, the enzyme is capable
of instigating factors that promote ECM accumulation such as increasing the
synthesis of ECM components whule simultaneously downregulating genes that
promote matrix degradation (41,44). And so, a potential new link between furin
and diabetes is made. If the expression of TGF- 3 is upregulated in diabetic
conditions, then active TGF- in tum increases the transcription of its own
activating enzyme furin. Although furin is overexpressed in a hyperglycemic
environrnent, as our biochemical resuits suggest, analysis by electron microscopy
leads us to believe that the enzyme is retained in the ER and Golgi compartments
of the protein-trafficking pathway. This prevents it from reaching the ccli surface
where cleavage of metalioproteases such as MT1-MMP can occur for GBM
maintenance and turnover.
1n 1994, Nakamura et al. pointed out that the expression ofmany metalloproteases
was downregulated in streptozotocin-induced diabetic rats (45). The abnormal
gene regulation ofMTl-MMP in particular was eventually linked to TGF- 3. In
high glucose conditions, TGf- /3 expression is increased and may alter MT1-
MMP promoter activity through inhibition (46). Defects at the MT1-MMP gene
transcription level in diabetic conditions thus accounts for the loss of its
proteolytic activities in GBM turnover as inactive species accumulate and active
membrane species are flot replenished. The decrease in MT1-MMP expression in
diabetes lias been widely reported in the literature (16-17,42,47) and was also
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observed by electron microscopy at the level of plasma membranes and Golgi
compartments of glomerular celis in our study.
TGF- 3 thus reveals itself as a double-edged sword; on the one hand it upregulates
furin gene transcription and on the other it downregulates MTY-MMP gene
transcription through indirect interactions with their promoter regions. An
upregulation in furin synthesis by TGF- f3 does not seem to compensate for TGf
f3 downregulation of GBM proteolytic proteins such as MT1-MMP, and
upregulation of ECM component synthesis like collagen; factors that contribute to
the thickening of the basement membrane as seen in glomeruÏosclerosis. As a
resuit, not only does furin have less of its substrate to cleave, but our electron
microscopy resuits seem to suggest that the proprotein convertase is retained in
the biosynthetic pathway. To substantiate this proposition, there is a need for
further studies involving other fin-in substrates that are also membrane-bound but
flot downregulated in diabetes. If expression of these proteins at the ceil surface
is reduced, then evidence for furin retention in the secretory pathway could be
further strengthened.
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TABLE 3
Quantitative Evaluation of Immunogold Labeling for Membrane Type-I
Metalloprotease over Podocytic Cellular Compartments
Endoplasmic GolgiAmmals . MitochondnaReticulum Apparatus
2 month, control 0.85±0.06
a 0.89±0.09 0.15±0.09
2 month, diabetic 0.77±0.05 0.86±0.1 0.16±0.12
12 month, control 0.44±0.04 0.45±0.1 0.19±0.03
12 month, diabetic 0.42±0.04 0.55±0.08 0.18±0.02
a Gold particles per hum, mean values ± SEM.
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TABLE 4
Quantitative EvaÏuation ofhnmunogold Labeling for Furin over Podocytic
Cellular Compartments
Animais Endoplasmic Golgi Mitochondria
Reticulum Apparatus
2 month, control 0.59+0.05
a 0.43+0.07 0.15+0.05
2 month, diabetic 0.55+0.06 0.46±0.07 0.12±0.06
12 month, control 0.85+0.08 0.64±0.07 0.20+0.05
12 month, diabetic 0.86+0.08 0.66+0.08 0.19±0.04
a Gold particles per 11m,, mean values ± SEM.
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LEGENDS
FIG.1: Electron micrographs of (A) short-term control and (B) long-term diabetic
rat renal tissues. Colloidai gold labeling demonstrates presence ofMTl-MMP in
the glomerular waÏÏ. There seems to be a significant decrease in labeling in
tissues of diabetic animais. Thickening of the glomerular basement membrane
(GBM) in the tissues of the diabetic animal (B) is evident. US= urinary space, P=
podocyte, CL= capillary lumen. Bars = 0.25 tm.
FIG.2: Electron micrographs of (A) short-term control and (B) long-term diabetic
rat renal tissues. Colloidal gold labeling of furin reveals less labeling in the
glomerular wall of the diabetic animal. US= urinary space, P= podocyte, CL=
capillary lumen. Bars 0.25 pm.
FIG.3: Western blot analysis of MTI-MMP in glomerular lysates: (a) 2 month
control, (b) 2 month diabetic, (c) 12 month control, (d) 12 month diabetic.
Varying band intensities were found at three molecular weights: the 63 kDa pro
form, the 57 kDa active form and the 44 kDa inactive form.
FIG.4: Western blot analysis of furin in glomerular lysates: (a) 2 month control,
(b) 2 month diabetic, (c) 12 month controÏ, (d) 12 month diabetic. The furin band
can be seen at 98 kDa.
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FIG.5: Electron micrograph of 2 month control rat renal tissue Golgi region of a
podocyte. GoÏd particles labeling MTI-MMP are found in rough endoplasmic
reticulum (RER) and Goigi (G) cistemae. Bar = 0.25 im.
FIG.6: Electron micrograplis of furin immunolabeling. Pericytes from (A) young
control and (B) old diabetic animais. A and B iliustrate rough endoplasmic
reticulum (RER) cistemae. The labeling is drastically increased in tissues of
diabetic animais. Pericytes from (C) young control and (D) old diabetic animais.
C and D illustrate the Golgi apparatus (G). Again iabeling is increased in tissues
ofdiabetic animais (D). Bars = 0.25 11m.
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Discussion
With the advent of increasingly refined morphological tools, we have sought to
shed additional light on the abnormal loss of proteins in the urinary space at an
ultrastructural level. It is now clear that generalized proteinuria is largely a resuit
of alterations in the selective filtration properties of the GBM, and that these
functional changes occur earlier than observable structural modifications (Doucet
et al., 1999). Nevertheless, that the thickening of the glomerular basement
membrane reflects biochemical modifications in its amino acid and sugar
composition, and that this aggravates proteinuria, has been known for quite some
time (Spiro and Spiro, 1968; Beisswenger and Spiro, 1970; 1973; Beisswenger,
1976; Spiro, 1976), and due to its complexity is stili a hot topic among
histochemical circles (Kanwar, 1984; Kim et al., 1991; Desjardins and Bendayan,
1990; moue and Bendayan, 1995; McCarthy, 1997; Regoli et al., 1998). Loss of
glomerular function in diabetes in particular, has been linked with modifications
in the selective properties of the glomerular wall (Deckert et al., 1988). Our
project sought to deepen our knowledge on the morphological and biochemical
changes that accompany basement membrane thickening in diabetes in order to
further clarify the events that lead to glomerular dysfunction.
The recent molecular era has exponentially increased our knowledge of the
biochemical modifications that accompany basement membrane thickening. 0f
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interest are the specific molecular interactions orchestrating basement membrane
turnover and maintenance. The matrix metalloproteases are a family of
endoproteases that were identified as key players in extracellular matrix turnover.
Our increased awareness of MMPs is mostly a resuit of their relevance in cancer
bioiogy, namely cancer-ce!! growth, differentiation, apoptosis, migration and
invasion, yet we are increasingly researching their mechanisms of action in other
pathological processes such as diabetes. When Yana and Weiss (2000)
demonstrated the existence of a furin cleavage site in the membrane type I matrix
metalloprotease, it became clear that cooperative interactions between proprotein
convertases and membrane-anchored MMP’s play an important role in regulating
the remodeling of the extracellular matrix. With respect to glomerniar fiiter
integrity, it also became clear that proper permselectivity relies on the delicate
interactions existing between synthetic and degradative pathways, and that
various forms of glomerniar diseases are characterized by shifis in this balance
(Del Prete et al., 199$; Lenz et al., 2000; Stamenkovic, 2003).
In the present study, the expression of membrane type-I matrix metalloprotease
and fin-in, two enzymes known to be crucial in extracellular matrix remodeling,
was evaÏuated in the glomenilar wall of diabetic rat renal tissues. This was done
with experimentally-induced diabetic rats by streptozotocin injection.
Streptozotocin selectively destroys pancreatic beta-celis and requires only one
dose to induce an hyperglycemic state in animais wich occurs within 48 hours, a
condition that remains throughout their lifetime. In this study, hyperglycemic
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states were maintained for 2 months (short-term) and 12 months (long-term)
before sacrifice. Male Sprague-Dawley rats were used because they
systematically develop symptoms and alterations that are characteristic of diabetic
glomerulopathies (Steffes and Mauer, 1984). Given that a small number ofbeta
pancreatic ceils survive streptozotocin treatment, injected rats are stiil capable of
producing smail amounts of insulin. This means they wiii perpetually maintain an
hyperglycemic state without requiring a constant suppiy of additional insulin.
Before sacrificing animais for study, the weight, glycosuria and glycemic leveis
were measured. Pathological conditions reflecting diabetes couid thus be
evaluated. Jndeed, glycemic levels and glycosuria were significantly higher in
rats injected with streptozotocin than nonnoglycemic animais, and corporai
weight significantÏy lower in those same diabetic animais.
for immunocytochemical techniques, the post-embedding technique was
employed. Colloidal protein A-gold was used to reveal the desired antigenic
sites; this method is useful for the high resolution it offers and the ease with
which morphometricai analyses can be carried out to determine its distribution in
the giomerular wall.
At high magnification under electron microscopy, it is possible to view the
distinct ceiiuiar structures that make up the glomerular wali. The endothelial ceils
are facing the capiilary lumen and the epithelial podocytes face the urinary space.
Mesangial celis are at the junction of podocytes and are embedded within the
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extracellular matrix whiie the epitheliai podocytic ceil bodies project onto the
GBM. Significant thickening of the GBM is only apparent in older
normoglycemic and hyperglycemic rat renai tissues. In 2-month old tissues,
GBM width is thinner and does flot differ significantiy between normal and
diabetic conditions. In addition, an important accumulation in mesangial
extracellular matrix can be observed in long-term diabetic tissues.
These observations confirm a recurring theme in the study of long-term diabetes,
one which proposes that the presence of diabetes accelerates the aging process
(Darmady et al., 1973; Bolton et al., 1976; Quagliano et al., 1993; Bendayan,
199$). For example, advanced glycated end (AGE) products were detected in the
renai extracellular matrix of old normoglycemic animais as well as younger
diabetic tissues, indicating that AGE products may participate in the pathogenesis
of renal complications (Bendayan, 1998). Indeed, in several instances
spontaneous glomeruloscierosis was observed in aging normogiycemic rat tissues
(Bolton et al., 1976; Quagliano et al., 1993). However, in instances where
chronic glycemia prevails, the process of glomeruiosceirosis is significantly
acceierated in younger animais (Couchman et ai., 1994; Lee et al., 1997). The
present study also noted significant GBM thickening due to increased deposition
and accumulation of proteins that make up the glomerular wail of both old
normoglycemic and hypergiycemic rat renal tissues. Most importantiy, our
resuÏts bring to attention two factors which most likely exacerbate this GBM
thickening: a decrease in MT1-MMP which cleaves a wide array of ECM
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substrates, concomitant with a decrease in furin, a proprotein convertase which
activates MT 1 -MMP.
Immunogold labeling consistently revealed the presence of MT1-MMP and furin
enzymes over the apical and basal plasma membranes of epithelial celis, the sut
diaphragm region, and the luminal and abluminal endothelial membranes.
General qualitative observations revealed that immunolabeling for both enzymes
was especially frequent in the luminal and abluminal membranes ofpodocytes, as
well as the sut diaphragms of young normal rat renal tissues. This is in
accordance with Mayer et al.’s findings on the co-localization of these proteins in
those same areas (Mayer et al., 2003). Moreover, Mayer et al. noted that
significant pools of furin and MT 1 -MMP were seen co-localized and concentrated
within the Golgi apparatus and intracellular vacuoles of podocytic celis as well as
over plasma membranes, suggesting that translocation ofpro-MT1-MMP through
the secretory pathway and onto the celi surface is facilitated by furin. Furinlpro
MT1-MMP complexes were also present at the sut diaphragm domain, at the
abluminal side of endothelial ceils facing the GBM and in the vicinity of
endothelial fenestrations (Mayer et al., 2003). Once recruited to defined plasma
membrane domains of the cell surface, it is proposed that pro-MT1-MMP is
activated by furin which allows for a type of focalized pericellular proteolysis that
could be implicated in GBM turnover (Mayer et al., 2003). Indeed, it has been
suggested that anchoring furin at the plasma membrane might provide a
mechanism for concentrating the protease in discrete regions where efficient
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extracellular processing could take place (Liu et al., 1997). Our observations of
MT1-MMP and furin immunolabeling over those same regions of the giomerular
wall of normal rat renai tissues provide additional support to Mayer et al.’s
proposition of a focalized pericellular proteolysis at the surface of celis.
The next step was to look at the expression and localization of MT1-MMP and
furin in the glomerular wall of rat renal tissues, but in hyperglycemic conditions.
We hypothesized that any modifications in expression at this level may signal
perturbations in focalized pericellular proteolysis normally carried out by these
enzymes for GBM turnover. Through morphometrical analysis of tissues of
short- and long- term diabetic animais, we found that both enzymes exhibit a
decrease in expression in ail evaiuated plasma membrane regions along with age,
an alteration that became more pronounced in the diabetic condition. The only
exception was the presence of extraceliular MT 1 -MMP within the glomerular
basement membrane which actually increased in old normal and diabetic rat renal
tissues. lnterestingly, there was a two-fold decrease in immunolabeling
specifically within the sut diaphragm regions of old diabetic tissue versus young
normal tissues. This observation lends additional credence to Mayer et al.’s
theory of focalized pericullar proteoiysis in specific plasma membrane
microdomains.
With the goal of corroborating immunocytochemical findings, western blots were
performed on glomeruiar lysates. Bands revealed three different forms of MT1-
7$
MMP; the pro (63 kDa) and active (57 kDa) forms which, as expected,
significantly diminished in intensity along with age and diabetes. Jnterestingly,
the truncated inactive form observed at 44 kDa actually increased in signaling
intensity. As reported by Osenkowski et al., the 44 kDa species is the inactive
degradation product of MT 1 -MMI? proteloytic processing at the celi surface,
which translates into a potential regulation mechanism of the protein (Osenkowski
et al., 2004).
The process of ectodomain shedding is well established as a major regulatory
mechanism that controls the activity of a variety of membrane-bound proteins on
the ce!! surface. Ectodomain shedding ofMTl-MMP was thoroughly explored by
Toth et al. who suggest that this mechanism evolved as a way to terminate MT1-
MMP activity at the celi surface (Toth et al., 2002). In this unique regulatory
mechanism, active MT1-MMP undergoes autocatalytic processing on the celi
surface which leads to the formation of an inactive 44 kDa species and release of
the entire catalytic domain (Toth et al., 2002). By disrupting enzyme integrity at
a vital structural site, ectodomain shedding regulates the pericelluar and
extracellular activities of MT1-MMP through a delicate balance of active and
inactive enzyme-soluble fragments. This process either switches the proteolytic
machinery from the cell surface to the pericellular space if the released fragments
are competent enzymes or may obliterate proteolysis, if the soluble fragments are
inactive andlor in a complex with TEVIPs (Toth et al., 2002). The loss of the
catalytic domain clearly terminates MT1-MMP activity on the cell surface but the
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remaining 44 kDa degradation product can also negativeiy influence enzymatic
activity. The 44 kDa species was shown to compete with the full-length enzyme
for coliagen binding, reducing collagenolytic activity (Tam et al., 2002). The
negative influence exerted by the 44-kDa species over MT1-MMP pericellular
processing activity may explain how its overabundance in tissues of diabetic
animais, as observed in our biochemical findings, stili slows down extracellular
matrix turnover. In contrast, inhibition of this shedding has been shown to lead to
an accumulation of the active enzyme on the celi surface and so an enhancement
in MT1-MMP proteolytic activity (Toth et al., 2002). In conclusion, Toth et al.
remark that the ability of ceils to elicit autocatalytic shedding depends on the
expression level of MT1-MMP on the ceil-surface and the levels and availability
of TIMPs. In the case of diabetes, our resuits suggest that MT1-MMP undergoes
autocalytic processing at the membrane, yet newly synthesized forms of the
protein are not replenished by the ceil. The result is an accumulation of the
inactive degradation product in the extracellular matrix, leading to a reduction in
pericellular proteolysis, which aggravates basement membrane thickening.
Osenkowski et al. point out that the total amount of MT1-MMP on the celi
surface depends on the balance between autocatalytic processing, internalization,
and de novo protein synthesis (Osenkwoski et al., 2004). The effect of
hyperglycemia on MT1-MMP autocatalysis and shedding stili remains cloudy, yet
studies documenting the influence of a high glucose environrnent on MT1-MMP
gene expression and synthesis are numerous (Nakamura et al., 1994; Lenz et al.,
$0
2000; McLennan et al., 2000; McLennan et al., 2002; Portik-Dobos et al., 2002;
Dolan et al., 2003; Mason and Wahab, 2003).
In 1994, Nakamura et al. observed that levels of mRNA encoding for many
metalloproteases was downregulated in streptozotocin-induced diabetic rats
(Nakamura et al., 1994). A new link between hyperglycemia and abnormal gene
regulation of MMPs was made. Subsequent studies on Mil -MMP expression in
a diabetic environment reported similar observations. MT1-MMP expression and
total MMP activity were decreased by two-fold in the arterial vasculature of
diabetic patients (Portik-Dobos et al., 2002). With respect to glomerular ceils,
McLennan et al. observed that high glucose concentrations can decrease
degradation of mesangium by reducing the activities of MT1-MMP and other
MMPs (McLennan et aI., 2002). Mason and Wahab extensively reviewed the
effect of diabetic nephropathy on extracellular matrix metabolism and charted the
increased and decreased activities of MMPs (Mason and Wahab, 2003). MMP-7,
MMP-9 and MT1-MMP mRNA diminish in expression in mesangial cells while
MMP-2 expression is augmented but activation seems to be reduced (McLerman
et al., 2000). The decrease in MT1-MMP expression in diabetes has thus been
well established in the mesangial matrix, suggesting a decrease in turnover and
therefore excessive matrix accumulation. Our study observed a similar pattem by
electron microscopy at the level of plasma membranes of epithelial and
endothelial ceils of the glomerular wall. When we extended our
immunocytochemical investigations to the biosynthetic pathways of podocytic
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celis, the putative sites of MT1-MMP synthesis, we noticed a drop in
immuno1abe1ing at the ER and Golgi cistemae of old diabetic rat renal tissues
versus young normal ones. These observations reconfirmed the drop in mRNA
expression ofMTl-MMP in a high glucose environment, a fact also supported by
our biochemical findings.
The abnormal gene regulation of MT1-MMP was eventually linked to growth
factor TGF- fi. To date, three TGF- fi isoforms have been identified (TGf- fil, f32,
and f33) in the mammalian species. The TGf- fis are a family of ubiquitously
expressed cytokines which have attracted much attention due to their pleitropic
biological activities (Blanchette et al., 1997). Biological processes in which TGF
f3 involvement is apparent include embryogenesis, ceil cycle arrest, wound
healing, ceil differention, tissue fibrosis, and most importantly with respect to our
study, increased synthesis of exracellular matrix components (McCartney-Francis
and Wahl, 1994).
Expression of TGF- fi in glomerular cells is weak in the normal state. It is now
well-documented that in high glucose conditions, the expression of ail three TGf
fi isoforms is increased (Dolan et al., 2003). There is extensive evidence for the
pathological role of TGF- fi in diabetic nephropathy. TGF- fi induces the
production of extracellular matrix components such as type-W collagen and
fibronectin (Marti et al., 1994). It also inhibits matrix turnover by down
regulating matrix metalloproteases and stimulating TIMPs (Dolan et al., 2003;
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McLeiman et ai., 2000). TGF- f3 thus doubly contributes in the increased
production of extracellular matrix in diabetes: first by up-regulating synthesis of
basement membrane components and second, by down-regulating synthesis of
endoproteases which cleave these components for matrix breakdown. TGf- fi has
indeed been demonstrated to interfere indirectly with the promoter regions of
MT1-MMP (McLennan et al., 2000). Defects at the MT1-MMP gene
transcription level in diabetic conditions is in accordance with our
immunocytochemical and biochemical findings which suggest that inactive MT1-
MMP species accumulate in the glomerular basement membrane whule active
membrane species are flot replenished at the surface from the biosynthetic
pathway.
Furin, on the other hand, gave conflicting resuits. Instead of a decrease in
expression, as seen in the glomerular walls of old normal and diabetic animais by
electron microscopy, the 98 kDa furin hand actualiy increased in intensity in oid
normal and diabetic rat tissues. Unsatisfied with the discrepancies obtained
between eiectron microscopy and biochemical resuits, we looked to further our
immunocytochemical investigations to the ER and Golgi membranes of
podocytes, also the putative sites of synthesis of the furin protease. Jndeed, furin
immunoiabeling was found concentrated over Goigi and ER cisternae of
podocytic ce!! bodies to a greater extent in old rat renal tissues than in their young
counterparts, a trend that was more significant in diabetic conditions. Therefore,
there is a possibiiity that furin, although transcribed and synthesized to a greater
$3
degree in a high glucose environrnent, associates with pro-MT1-MMP in the
Golgi but remains trapped in the trafficking pathway. If furin cannot shuttie pro
MT1-MMP to the ceil surface, then it cannot activate the metalloprotease for
focalized pericellular proteolysis essential to GBM turnover.
In 1997, Blanchette et al. released a paper linking furin expression with none
other than growth factor TGF-3. Their study brought to light an activation ioop
existing between growth factor TGF-3 and furin (Blanchette et al., 1997). In a
previous study, furin had been identified as the converting enzyme responsible for
generating mature TGF-f3 by cleaving the R-H-R-R sequence motif (Dubois et al.,
1995). The promoters regulating furin gene (frr) having been cloned (Ayoubi et
al., 1994), Blanchette et al. were able to demonstrate that TGF-f3 is capable of
coercingfur gene promoters into augmenting furin transcription levels. The resuit
is an auto-feedback loop mechanism, in which TGf-$ upmodulates fur gene
expression, which in tum increases pro-TGf-t3 maturation (Blanchette et al.,
1997). As we have seen, the role of TGF-3 in diabetic kidney disease is well
documented (Dolan et al., 2003; Lenz et al., 2000; Del Prete et al., 199$; Portik
Dobos et aÏ., 2002). In celis treated with high glucose concentrations, a
significant rise in TGF-3 mRNA expression is observed as early as 24h after the
onset of hyperglycemia (Dolan et al., 2003). And so, a potential new link
between furin and diabetes is made. If the expression of TGF-f3 is upregulated in
diabetic conditions, then active TGF-fl in tum increases the transcription of its
own activating enzyme furin. Although furin is overexpressed in a hyperglycemic
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environment as our biochemical resuits suggest, analysis by electron microscopy
leads us to believe that the enzyme is retained in the ER and Golgi compartments
of the protein-trafficking pathway. This would prevent it from reaching the celi
surface where cleavage of metalloproteases such as MT1-MMP can occur for
GBM maintenance and turnover.
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Conclusion
The expression and iocalization of enzymes essential to glomerular basement
membrane maintenance and renewal was evaiuated in the renal tissues of normal
and diabetic rats. By employing immunocytochemicai techniques, we observed a
significant drop in the expression of both MT 1 -MMP and furin in seiected
membrane domains of the glomerular waIl of animais exposed to a hypergiycemic
environment. There thus appears to be aiterations at the level of proteins
mediating basement membrane turnover at the glomentiar ceil plasma membranes
of diabetic animais. Interestingly, there was a two-foid decrease in expression of
both proteins specifically in the sut diaphragm regions at the junction of
podocytes and GBM. That MT1-MMP and furin activity is concentrated in the
sut diaphragm regions was an idea advanced by Mayer et al. (2003) who detected
frequent co-iocalization of these proteins in those specific areas. Our resuits
suggest that the proposed mechanism of focalized pericellular proteolysis
mediated by MT1-MMP and furin at the ceil surface ofpodocytes is disrnpted in
diabetic conditions.
While western biots confirmed a diminution in expression in the active form of
MT1-MMP, the bands representing the inactive shed form ofthe protein appeared
to increase in intensity in oid diabetic animais. Indeed, immunoiabeiing of shed
forms of MT1-MMP in the giomeruiar basement membranes of diabetic animais
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was greater than that of normal animais, indicating an increase in the autocataiysis
ofthe endoprotease at the ceii surface ofpodocytes.
Biochemical resuits for furin, on the other hand, gave contrary resuits to what was
expected. Instead of decreasing in signaling intensity, the bands representing
furin increased with respect to age, and were the most intense in old diabetic
animais. In light ofthese biochemical observations, the possibility was raised that
furin may be residing elsewhere than the celi surfaces of glomerular celis.
Immunocytochemical investigations were thus extended to the biosynthetic
pathway of podocytic ceil bodies where furin is believed to shuttie proteins
towards the celi surface. Additional quantitative evaluations of furin labeling in
the ER and Goigi cistemae indeed signaled the increased presence and retention
of furin in those membranes under diabetic conditions.
It was found in the iiterature that the furin gene contains a promoter region that
can be activated by TGf-t3 (Bianchette et ai., 1997). The increased expression of
TGF-3 has been demonstrated in hyperglycemic conditions (Doian et ai., 2003;
Lenz et ai., 2000), and in iight of this study a potentiai new link betveen furin,
TGf-13, and diabetes is made. While augmented levels of TGF-13 in high glucose
conditions act positively on the promoter region of furin to increase its
expression, the protease does not reach the ceil surface due to its retention in the
biosynthetic pathway of podocytes and so cannot perform its duty as activator of
basement membrane endoproteases such as MT1-MMP. furthemore, TGf-f3 has
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already been shown to downregulate MMP expression (McLennan et ai., 2000)
and upregulate the synthesis ofECM components (Marti et al., 1994), two factors
which only contribute further to the thickening of the glomerular basement
membrane.
To verify that furin is indeed biocked in the biosynthetic pathway of podocytes,
there is a need for fiirther studies involving other furin substrates that are aiso
membrane-bound but flot downregulated in diabetes. Therefore, if expression of
these proteins at the ceil surface is reduced, then this would provide additionai
evidence that the retention of furin in the secretory pathway impinges on proper
localization and ftmction of furin and its substrate for pericellular proteolysis at
ceil surface membranes. This would highlight a new pathological foie for furin in
diabetes and offer insights into potential therapeutic targets for reducing basement
membrane thickening in diabetic glomeruioscierosis.
Finally, the similar alterations in morphological charactersistics and protein
expression observed in 12-month old normal and diabetic tissues provides
additional weight to the theory that diabetes fosters an acceieration in the aging
process. Changes that thus occur under normai circumstances in the giomerular
waÏl with age, i.e. podocyte effacement as well as basement membrane thickening
and mesangial matrix expansion, are thus significantly enhanced in a
hypergiycemic environment. Our study further supports this by demonstrating the
decreased expression of MT1-MMP and fririn in both normal and diabetic 12-
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month old rat renal tissues, a factor which probably correlates with the basement
membrane thickening observed in those older animais.
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